🇺🇸 FDA
Patent

US 9980924

Topical pterostilbene compositions for use in treating UV-induced loss of barrier function in skin

granted A61KA61K31/09A61K47/26

Quick answer

US patent 9980924 (Topical pterostilbene compositions for use in treating UV-induced loss of barrier function in skin) held by The Regents of the University of California expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/09, A61K47/26, A61K9/0014, A61K9/08